Increased risk of NASH in patients carrying the C(-159)T polymorphism in the CD14 gene promoter region
- 27 September 2005
- Vol. 55 (8), 1212
- https://doi.org/10.1136/gut.2006.093336
Abstract
Non-alcoholic fatty liver (NAFL) is a common hepatic disorder that progresses to non-alcoholic steatohepatitis (NASH) in only 20% of patients. Whereas polymorphisms in genes involved in fat metabolism confer susceptibility to NAFL,1 the risk factors involved in the progression of the disease to NASH are not known. A possible role for intestinal derived bacterial endotoxins in the progression from NAFL to NASH is gaining increasing interest in view of recent experimental data. Thus NASH patients show a higher prevalence of small intestinal bacterial overgrowth (SIBO) and, in animal models of SIBO, hepatitis is improved following antibiotic treatment.2,3 Furthermore, we have recently observed that increased intestinal mucosal permeability, such as that observed in obese C57BL/6J ob/ob mice, leads to higher lipopolysaccharide (LPS) levels in …Keywords
This publication has 9 references indexed in Scilit:
- Exposure to bacterial cell wall products triggers an inflammatory phenotype in hepatic stellate cellsAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2005
- Polymorphisms of microsomal triglyceride transfer protein gene and manganese superoxide dismutase gene in non-alcoholic steatohepatitisJournal of Hepatology, 2004
- Toll–Like Receptor 4 Mediates Inflammatory Signaling by Bacterial Lipopolysaccharide in Human Hepatic Stellate CellsHepatology, 2003
- Is obesity an inflammatory condition?Nutrition, 2001
- Promoter Polymorphism of the Cd14 Endotoxin Receptor Gene As A Risk Factor for Alcoholic Liver DiseaseHepatology, 2001
- The role of small intestinal bacterial overgrowth, intestinal permeability, endotoxaemia, and tumour necrosis factor alpha in the pathogenesis of non-alcoholic steatohepatitisGut, 2001
- TLR4 mutations are associated with endotoxin hyporesponsiveness in humansNature Genetics, 2000
- Sp1 is a critical factor for the monocytic specific expression of human CD14Journal of Biological Chemistry, 1994
- Hepatic injury associated with small bowel bacterial overgrowth in rats is prevented by metronidazole and tetracyclineGastroenterology, 1991